Overview

An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to Evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of VR942 in healthy subjects (part 1) and repeated doses in mild asthmatics (part 2).
Phase:
Phase 1
Details
Lead Sponsor:
Vectura Limited
Collaborator:
UCB Pharma